Verisian
Verisian provides solutions for clinical trial analysis, validation, submission, and review, aiming to accelerate the delivery of treatments to patients. Their core offering, 'Validated by Verisian,' leverages Full Study Traceability through advanced graph analytics to create a dependency graph of specifications, metadata, code, and data. This technology eliminates the need for double programming, offering greater transparency, quality control, and faster decision-making. Verisian also offers AI co-pilots fine-tuned for clinical trial analysis to assist with tasks like code generation and documentation. The company supports pharmaceutical companies, biotechs, CROs, and regulatory agencies, with its technology being praised for its revolutionary approach to clinical programming and data traceability.
Verisian
Verisian provides solutions for clinical trial analysis, validation, submission, and review, aiming to accelerate the delivery of treatments to patients. Their core offering, 'Validated by Verisian,' leverages Full Study Traceability through advanced graph analytics to create a dependency graph of specifications, metadata, code, and data. This technology eliminates the need for double programming, offering greater transparency, quality control, and faster decision-making. Verisian also offers AI co-pilots fine-tuned for clinical trial analysis to assist with tasks like code generation and documentation. The company supports pharmaceutical companies, biotechs, CROs, and regulatory agencies, with its technology being praised for its revolutionary approach to clinical programming and data traceability.
TL;DR
What: Platform for validation of clinical trial analyses using "Full Study Traceability" (linking specs, code, data, and results).
Stage & funding: Seed stage (Seed round 2025-05-29); total funding reported ~5,570,000 USD.
Founders / Leadership: Tomás Sabat Stöfsel (CEO & Co‑Founder) and Dr. Henning Kuich (CTO & Co‑Founder).
Headquarters & founding year: London, England; founded 2023.
Primary market: Pharma, biotech, CROs and regulatory agencies for clinical trial analysis, validation, submission and review.
Company Overview
Problem Domain
Clinical trial analysis validation, submission, and review workflows.
Founded
2023
Industry
Clinical trial analysis and validation software
Tech Stack
Funding Track Record
4300000.00 USD
Seed round reported May 29, 2025; participants included Dimension Capital (lead) and other investors such as SuperSeed Ventures.
Pre‑Seed round reported Aug 17, 2023; individual investors listed for that date include Armen A. Vidian and Endre Sagi.
Investor Signal
“Backed by a mix of VCs and angel investors (reported investor count: 9), including VC firms Seedcamp and Dimension Capital and early‑stage investors such as SuperSeed Ventures.”